CN Patent

CN114206869A — Cxcr4抑制剂和其用途

Assigned to X4 Pharmaceuticals Inc · Expires 2022-03-18 · 4y expired

What this patent protects

本发明涉及抑制4型C‑X‑C受体(CXCR4)的化合物和方法。本发明还提供包含本发明化合物的药学上可接受的组合物和使用所述组合物治疗各种疾病的方法。

USPTO Abstract

本发明涉及抑制4型C‑X‑C受体(CXCR4)的化合物和方法。本发明还提供包含本发明化合物的药学上可接受的组合物和使用所述组合物治疗各种疾病的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN114206869A
Jurisdiction
CN
Classification
—
Expires
2022-03-18
Drug substance claim
No
Drug product claim
No
Assignee
X4 Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.